Natural Killer (NK) Cell Therapeutics Market – 2021 Predictive Analytics || INmuneBIO, Gamida Cell, Bellicum Phamaceuticals

Data Bridge Market Research presents an latest and updated Study on Natural Killer (NK) Cell Therapeutics Market Size 2021-2027. The report offers market prophesy related to market, revenue, Size, production, Consumption, CAGR, price, gross margin, and other major factors. This report covers key player’s strategies that mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that advance their footprints in the Natural Killer (NK) Cell Therapeutics industry. The report also contains a complete study of the developments and future trends of the market. It also informs about the trending innovation and business policies. Natural Killer (NK) Cell Therapeutics market businesses can get clear idea about how the market is going to perform in the forecast years with understandable details about market definition, classifications, applications, and engagements. The report highlights on the competitive scenario of the -market for knowing the competition at the regional levels. It analyzes key segments and their sub-segments, revenue and demand & supply data. The report provides complete analysis (including full toc, 100+ tables & figures, and chart) in-depth analysis pre & post COVID-19 market outbreak impact analysis & situation by region such as North America, China, Europe, Southeast Asia, Japan, and India, with respect to the production, price, revenue and market share for top manufacturers.

Natural Killer (NK) Cell Therapeutics market

The natural killer (NK) cell therapeutics market is expected to gain market growth in the forecast period of 2021 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 40.5% in the forecast period of 2021 to 2027 and is expected to reach USD 1,006.39 million by 2027. Increase in usage of natural killer (NK) cell for the treatment of cancer and infectious diseases and rise in awareness about immunotherapies are the major drivers which propelled the demand of the market in the forecast period.

Download Free Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry @

Major Market Players With An In-Depth Analysis:

  • Kiadis Pharma
  • Cytovia Therapeutics
  • Nkarta, Inc
  • Fate Therapeutics
  • EMERcell
  • Glycostem
  • Phio Pharmaceuticals, Innate Pharma, Inc
  • INmuneBIO
  • Gamida Cell
  • Bellicum Phamaceuticals, Inc
  • Acepodia Inc
  • Affimed GmbH

The Study Is Segmented By Following:

By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies)

By Application (Cancer, Acute Infectious Diseases, Immunoproliferative Disorders, Gastrointestinal Diseases, Others)

By End User (Hospitals, Specialty Clinics, Research & Academic Institutes)

Natural Killer (NK) Cell Therapeutics market report is very indispensable in many ways for business growth by following a number of steps of collecting and analysing market data, the finest Natural Killer (NK) Cell Therapeutics market research report is framed with the expert team. This global market report consists of all the company profiles of the major players and brands. In addition, competitor analysis is carried out very well in this market report which takes into account vital aspects about the key players in the market such as strong and weak points of the competitors and analysis of their strategies with respect to product and market. Every possible effort has been taken while researching and analysing information to prepare Natural Killer (NK) Cell Therapeutics market report. The purpose of this report is to describe the upcoming market trends and earnings forecasts in the global Natural Killer (NK) Cell Therapeutics market for the next five years.

Years considered for these Natural Killer (NK) Cell Therapeutics Market reports:

Historical Years: 2016-2019

Base Year: 2021

Estimated Year: 2027

Natural Killer (NK) Cell Therapeutics Market Forecast Period: 2021-2028

To receive extensive list of important regions, ask for TOC here @

TOC of Global Natural Killer (NK) Cell Therapeutics Market:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the Natural Killer (NK) Cell Therapeutics Market.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the Natural Killer (NK) Cell Therapeutics market.
  • Market Development: Comprehensive information about emerging market. This report analyses the market for various segments across geographies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Natural Killer (NK) Cell Therapeutics Market.
  • Market Growth: The growth factors of the market are discussed where the different users of the market are described in detail.
  • Market Segmentation: Data and information by market player, by region, by type, by application, etc and custom research can be added.
  • Appendix: The final of the report contains conclusion part where the industrial experts opinions are included.

Global Natural Killer (NK) Cell Therapeutics Market Scope and Market Size

On the basis of therapeutics, the natural killer (NK) cell therapeutics market is segmented into NK cell therapies and NK cell directed antibodies.

On the basis of approaches, the natural killer (NK) cell therapeutics market is segmented into antibody-dependent cell-mediated cytotoxicity (ADCC) and bispecific antibodies.

On the basis of application, the natural killer (NK) cell therapeutics market is segmented into cancer, acute infectious diseases, immunoproliferative disorders, gastrointestinal diseases and others.

On the basis of end user, the natural killer (NK) cell therapeutics market is segmented into hospitals, specialty clinics and research & academic institutes.

Competitive Landscape and Natural Killer (NK) Cell Therapeutics Market Share Analysis

The major companies which are dealing in the natural killer (NK) cell therapeutics are Kiadis Pharma, Cytovia Therapeutics, Nkarta, Inc., Fate Therapeutics, EMERcell, Glycostem, Phio Pharmaceuticals, Innate Pharma, Inc., INmuneBIO, Gamida Cell, Bellicum Phamaceuticals, Inc., Acepodia Inc., Affimed GmbH, multimmune GmbH, Bristol-Myers Squibb Company, Kleo Pharmaceuticals, iCell Gene Therapeutics, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals Inc., NantKwest and Merck KGaA among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the natural killer (NK) cell therapeutics market.

For instance,

  • In July 2020, Kiadis Pharma had licensed its product pipeline K-NK004 to Sanofi. This product is indicated for treatment of multiple myeloma. This agreement helped the company to earn USD 20.67 million upfront which allowed it to boost up its drug development procedure.
  • In August 2020, Cytovia Therapeutics had filed a patent application for iPSC-Derived NK Cells in partnership with the New York Stem Cell Foundation (NYSCF) Research institute in order to produce the unlimited on demand NK and CAR- NK cell for treatment of cancer.

Natural Killer (NK) Cell Therapeutics Market Country Level Analysis

The countries covered in the global Natural Killer (NK) Cell Therapeutics market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

Any query? Enquire Here For Discount (COVID-19 Impact Analysis Updated Sample):

Key questions answered in the report:

  • What is the complete insights into current industry trends, growth drivers, trend forecast about Natural Killer (NK) Cell Therapeutics market?
  • Which product segment will grab a Natural Killer (NK) Cell Therapeutics market share with the latest analysis of market share, challenges growth drivers, and investment opportunities?
  • Which segment’s market dynamics and trends have been mentioned across application and geographical areas?
  • Which regional market will emerge as a frontrunner in coming years?
  • Which Market Segmentation up to three or four level provided in the report?
  • What are the growth opportunities that may emerge in Natural Killer (NK) Cell Therapeutics industry in the years to come?
  • What are the key challenges that the global Natural Killer (NK) Cell Therapeutics market may face in future?
  • Which are the profiles of the key industry players across each regional market, their growth strategies, market shares, and product portfolios?
  • Which are the Patent estimation, including coverage of the current state of technology, newly issued patents and new patent applications?
  • Which are the growth strategies considered by the players to sustain hold in the global Natural Killer (NK) Cell Therapeutics market?
  • What are extensive research information on major drivers and current trends within the industry and regional dynamics of the market?

 Thanks for reading this article, you can also get individual chapter wise section or region wise report version like South America, Eastern Europe, Middle East or Southeast Asia.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475


Back to top button